S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip Philip
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
146 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nea Baptist Memorial Hospital
Jonesboro, Arkansas, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- City of Hope Medical Center
Duarte, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Glendale Memorial Hospital and Health Center
Glendale, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group
Greenbrae, California, United States
- University of Southern California
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- El Camino Hospital
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Breast Surgeons Inc
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Larry G Strieff Md Medical Corporation
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- University of California Medical Center at Irvine-Orange Campus
Orange, California, United States
- Valley Care Health System - Pleasanton
Pleasanton, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
- Sutter Solano Medical Center
Vallejo, California, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Atlanta Regional Ccop
Atlanta, Georgia, United States
- Northside Hospital
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Well Star Cobb Hospital
Austell, Georgia, United States
- John B Amos Cancer Center
Columbus, Georgia, United States
- Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Harbin Clinic Medical Oncology and Clinical Research
Rome, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Saint Joseph'S-Candler Health System
Savannah, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 1 Sept 2012
- Completion
- 25 Feb 2014
- Last update posted
- 8 Feb 2022
- Registered enrollment
- 134
- Registry id
- NCT00617708
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.